Healthcare Policy and Regulation

The Joint Federal Committee (G-BA) has introduced significant amendments to the out-of-hospital intensive care (AKI) guidelines, aiming to streamline potential assessments and adapt to...

A significant funding boost aims to revolutionize support systems for vulnerable children in care through the newly launched NEST Study, led by the Pennine...

Key TakeawaysEnhanced Due Process Mandates advance notice and fair hearings before eligibility termination. Strict Sanction Criteria Limits recoupments and disallows wrongful lock-outs. Clear Definitions...

Novartis has unveiled promising results from the Phase IIIB APPULSE-PNH study, showcasing Fabhalta's (iptacopan) capability to enhance hemoglobin levels in adults battling paroxysmal nocturnal...

Key TakeawaysShorter antibiotic courses can potentially decrease healthcare costs and reduce the risk of antibiotic resistance. Efficient antibiotic stewardship aligns with global initiatives...

A comprehensive Canadian study conducted by the National Vaccine Safety Network has affirmed the robust safety of mRNA COVID-19 vaccines among children and adolescents....

In a series of impactful decisions, the U.S. Food and Drug Administration unveiled new guidelines for accelerated drug approvals, tackled ongoing medical device shortages,...

Amgen has unveiled groundbreaking results from the Phase 3 AALL1731 study, showing that the inclusion of BLINCYTO (blinatumomab) in chemotherapy regimens markedly enhances disease-free...

Incyte announced that its Phase 3 POD1UM-304 trial demonstrated significant improvements in overall survival when retifanlimab (Zynyz) was combined with platinum-based chemotherapy for patients...

Leaders from the United States, Australia, India, and Japan recently launched the Quad Cancer Moonshot Initiative aimed at reducing cervical cancer in the Indo-Pacific...

Canada's Drug Agency has embarked on a strategic initiative following the royal assent of An Act respecting pharmacare on October 10, 2024. Responding to...

Eisai and Biogen have achieved a pivotal milestone with Mexico’s COFEPRIS approving LEQEMBI, a humanized monoclonal antibody designed to treat early-stage Alzheimer’s disease. This...

Germany's Federal Joint Committee (G-BA) has initiated a routine practice data collection (RPDC) plan for Marstacimab, a cutting-edge treatment for severe Hemophilia A and...

Germany is undertaking a significant update to its Disease Management Program (DMP) for rheumatoid arthritis (RA), aiming to align it more closely with the...

The Committee for Veterinary Medicinal Products (CVMP) concluded its session from December 3-5, 2024, with significant approvals and strategic advancements aimed at bolstering veterinary...